GLP-1 medications, or glucagon-like peptide-1 receptor agonists, work by mimicking the action of the naturally occurring hormone GLP-1, which is produced in the gut after eating
rhamnosus LR 32, B
It is proposed that this specific peptide sequence may have a significant impact on cellular communication processes, specifically targeting fibroblasts
[35,36] Furthermore, GLP-1 can assist in weight management, a valuable attribute for GDM patients as obesity exacerbates insulin resistance and glucose intolerance
Fink M, Abenhardt W, Ostermayr B, Berger M
Research published in PMC shows that glutathione administration suppresses muscle fatigue induced by prolonged exercise through improved aerobic metabolism